State of Alaska Department of Revenue’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.3M Buy
11,478
+1,008
+10% +$115K 0.01% 913
2025
Q1
$1.1M Sell
10,470
-269
-3% -$28.3K 0.01% 964
2024
Q4
$1.15M Buy
10,739
+314
+3% +$33.6K 0.01% 984
2024
Q3
$1.04M Buy
10,425
+510
+5% +$51K 0.01% 1044
2024
Q2
$835K Sell
9,915
-70
-0.7% -$5.9K 0.01% 1103
2024
Q1
$729K Sell
9,985
-99
-1% -$7.23K 0.01% 1206
2023
Q4
$720K Sell
10,084
-74
-0.7% -$5.28K 0.01% 1180
2023
Q3
$608K Sell
10,158
-639
-6% -$38.2K 0.01% 1225
2023
Q2
$778K Sell
10,797
-193
-2% -$13.9K 0.01% 1118
2023
Q1
$808K Sell
10,990
-185
-2% -$13.6K 0.01% 1093
2022
Q4
$746K Sell
11,175
-6,626
-37% -$442K 0.01% 1139
2022
Q3
$956K Sell
17,801
-2,642
-13% -$142K 0.01% 940
2022
Q2
$1.14M Buy
20,443
+1,803
+10% +$100K 0.01% 885
2022
Q1
$1.31M Sell
18,640
-328
-2% -$23K 0.01% 856
2021
Q4
$1.83M Sell
18,968
-537
-3% -$51.7K 0.02% 757
2021
Q3
$1.7M Buy
19,505
+15,360
+371% +$1.33M 0.02% 791
2021
Q2
$339K Sell
4,145
-28
-0.7% -$2.29K ﹤0.01% 1560
2021
Q1
$396K Sell
4,173
-16
-0.4% -$1.52K ﹤0.01% 1500
2020
Q4
$259K Sell
4,189
-202
-5% -$12.5K ﹤0.01% 1557
2020
Q3
$261K Sell
4,391
-184
-4% -$10.9K ﹤0.01% 1475
2020
Q2
$319K Buy
4,575
+24
+0.5% +$1.67K ﹤0.01% 1422
2020
Q1
$206K Sell
4,551
-77
-2% -$3.49K ﹤0.01% 1440
2019
Q4
$301K Sell
4,628
-793
-15% -$51.6K ﹤0.01% 1486
2019
Q3
$336K Buy
+5,421
New +$336K ﹤0.01% 1407
2018
Q4
Sell
-11,256
Closed -$1.93M 1668
2018
Q3
$1.93M Buy
11,256
+88
+0.8% +$15.1K 0.03% 545
2018
Q2
$1.44M Buy
11,168
+256
+2% +$33.1K 0.03% 601
2018
Q1
$1.12M Buy
10,912
+4,168
+62% +$429K 0.02% 648
2017
Q4
$576K Buy
6,744
+112
+2% +$9.57K 0.01% 743
2017
Q3
$563K Buy
6,632
+610
+10% +$51.8K 0.03% 665
2017
Q2
$456K Buy
6,022
+2,656
+79% +$201K 0.03% 461
2017
Q1
$222K Buy
3,366
+64
+2% +$4.22K 0.02% 626
2016
Q4
$209K Buy
+3,302
New +$209K 0.02% 422